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1. Introduction 
Cytochrome c oxidase is a complex, seven subunit 
enzyme containing two copper atoms, Cu, and CUB, 
and two hemes, the low-spin heme a and the high- 
spin heme a3 (fig.1). Located at the terminus of the 
mitochondrial respiratory chain it has the crucial 
role of catalysing the rapid, four electron reduction 
of molecular oxygen to water (reviewed Ila,b]). The 
oxygen binding site is known from abundant 
spectroscopic and chemical evidence to be at the 
heme a3. An intriguing structural aspect of this 
active site in its oxidized form is the strong anti- 
ferromagnetic coupling between the presumed high- 
4H+ 
F&l. Schematic representation of cytochrome c oxidase in 
its oxidized form. The hemes are represented as elipses. 
Heme a is low-spin and heme a 3 is high-spin. 
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spin S = 5/2 Fe(II1) heme a3 and the S = l/2 Cun(II) 
atom making these two metals electron paramagnetic 
resonance (EPR) ‘invisible’ and lowering their magnetic 
susceptibilities [2,3]. The strength of this antiferro- 
magnetic coupling is quantified by J, the exchange 
coupling constant, which is >200 cm- ’ for the oxidase 
[4]. The heme a3 and CuB are assumed to be in close 
proximity and bridged by a ligand which can mediate 
very strong magnetic exchange. Since the structure of 
the active site must be known in order to understand 
the catalytic mechanism there have been numerous 
suggestions regarding its nature. This communication 
briefly, but critically, analyses existing proposals in 
the light of recent model compound studies and con- 
cludes by discussing a model prejudiced in favor of 
oxygen bridged species. 
2. Discussion 
2.1. The imidazolate model 
The proposal of a CUB@-imidazolate-Fe(I11) 
heme a3 structure using a deprotonated axial histidine 
[S] (fig.2a) has been strongly adopted by Palmer [3]. 
Supportive evidence comes from several hemoglobin- 
like properties of heme ~3 particularly axial N EPR 
hyperflle splitting in the NO adduct and also circum- 
stantially from the probable existence of a Cu- 
imidazolate-Zn bridge in a superoxide dismutase. We 
have recently synthesized a variety of imidazolate 
bridged metalloporphyrins [6] all of which show that 
imidazolate is a rather poor mediator of antiferro- 
magnetic coupling. One further new result, which at 
first sight seems far removed from an oxidase model, 
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Fig.2. (a) The imidazolate model [ 31. (b) A Co(lI)-imidazolate- 
MN(H) face-to-face porphyrin species using the porphyrin 
reported in [6]. 
is that the Mn(II)-imidazolate-Co(I1) species in 
fig2b has -J = 5 cm-’ 171. Despite the different 
metals this is the first test of imidazolate coupling 
between an S = 5/2 metal (like Fe(II1) and an 
S = l/2 metal (like Cu(I1)) and moreover, the orbital 
occupations are very closely related to what we 
expect in an authentic Fe-Cu model [8]. Such low 
values of-J, taken together with those of other 
workers [9-l I] for Cu(I1) imidazolate dimers 
(J = 25-90 cm-‘) and all definitively characterized 
species [6,12] suggest hat imidazolate is not capable 
of mediating the strong coupling observed in cyto- 
chrome oxidase 0200). Cyanide-treated oxidase [4] 
has -J = 60 cm-’ which does fall into the range of 
known values in model systems. However, considera- 
tion of the probable mismatch of mutual orbital 
symmetries of the unpaired electrons (n on Fe and u 
on Cu) leads us to predict that this low-spin Fe(III)- 
imidazolate-Cu(I1) situation would have very small 
or negligible antiferromagnetic coupling. 
2.2. Various sulfur models 
Recent X-ray evidence pointing towards a Cu(1) 
oxidation level in the oxidized enzyme [ 131 has 
revived discussion on the possibilities of cysteinate 
radical [ 141, a Cu(II1) state, and other sulfur ligands 
[ 151. If only because there is a total lack of precedent 
for such structures in metalloproteins we tend to dis- 
favor them. 
2.3. Ehe bridging carboxylate model 
Seiter [ 161 has suggested that a carboxylate group 
might bridge CUB and heme u3. This is an attractive 
proposal because there is good inorganic precedent for 
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strong antiferromagnetic oupling at least in dicarboxyl- 
ate dimers and also there is bridging ligand precedent in 
hemerythrin. Proton transfer from a carboxylic acid 
to oxygen during reduction offers an additional role 
to this group. 
2.4. The bridgihg oxygen model 
We now propose a bridging oxygen model (fig.3) 
which is consistent with all available experimental 
data. Some aspects of the model have their origin in 
previous hypotheses [ 17,181. By assembling this 
model we can focus attention on what may turn out 
to be a rather simple picture of cytochrome oxidase 
and one which is based on sound inorganic chemical 
and biochemical principles. The resting, oxidized state 
of the enzyme, I (fig.3), has a /.NJXO Fe(III)-O- 
Cu(I1) moiety. Strong antiferromagnetic coupling in 
Fe-O-Fe dimers (J = 95-146 cm-‘) [ 191 and a 
diamagnetic Cu-0-Cu carbonate dimer [20] provide 
good precedent for the prediction that an Fe-0-Cu 
linkage, probably linear, could have -J > 200 cm-‘. 
Alteration of this bridge by various anions would 
lower (cyanide) or abolish (sulfide [21]) coupling. An 
axial histidine ligand is proposed in the sixth coordi- 
nation site but quite possibly is not coordinated at 
?I I (oxidized resting state) 
Fig.3. The bridging oxygen model. Heme a, is represented by 
the elipse. 
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this stage since ligation of ~.l-oxo ferric heme dimers is 
undocumented. Moreover, a mutant hemoglobin, 
Boston M, provides definitive biological precedent for 
proximal histidine dissociation accompanying ‘distal’ 
oxyanion coordination [22]. As reduction proceeds 
the oxide ligand will be expelled as a water molecule 
(fig.3). One electron reduction to state II destroys 
the antiferromagnetic coupling and provides an 
explanation for the observation of minor high-spin 
ferric heme signals and additional Cu intensity in 
the EPR spectra of partially reduced oxidase [ 16,231. 
Further reduction to state III gives the necessary 
deoxyhemoglobin-like high-spin ferrous heme which 
can rapidly bind dioxygen to give state IV, a species 
identified at low temperature by Chance [ 181. Since 
a vacant coordination site has probably been generated 
at CUB(I) it is reasonable to propose the p-peroxo 
dimer V. There is good inorganic precedent for such 
species 1241, hemocyanin and hemerythrin have this 
possibility, and also, a species proposed to be this has 
been observed at low temperature [ 181. A further 
two electron reduction (the electrons being supplied 
by heme a and the other copper(I), CuA , both of 
which we consider to have a ‘battery and wire’ func- 
tion) would extrude the second water molecule, 
balancing the overall reaction stoichiometry, and 
returning the enzyme to its resting oxidized state, I, 
Further attractive features of this mechanism are: 
(i) The natural way the overall four electron reduc- 
tion of dioxygen is broken down into at least 
three steps; 
(ii) The obvious compatibility with very fast reac- 
tion kinetics; 
(iii) Th e IO o ca e rciency of having the reaction b’ 1 gi 1 ff 
product as the bridging ligand. 
In summary, we favor an oxygen-bridged species 
for the oxidized CuB(II)/Fe(III) heme a3 active site 
of cytochrome c oxidase. While carboxylate oxygen 
or even hydroxide ion are viable candidates we 
presently prefer an oxide bridge as a working hypo- 
thesis in the design of experiments to elucidate the 
catalytic mechanism. 
This work is supported by the National Institutes 
of Health (GM 23857). 
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